CD274 and neoplasm: Furthermore, the mechanism by which 2-methoxyestradiol, a microtubule inhibitor presently enters pre-clinical trials and clinical research in GBM, inhibits MDSC activation by suppressing the expression of the hypoxia-derived exosomal miR-1246 in tumor cells and PD-L1 expression in MDSCs has been identified (107).